Povidone Iodine Irrıgation at Hip-Knee Arthroplasty
Sponsor
Ankara University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05599841
Collaborator
(none)
120
1
2
4
29.7
Study Details
Study Description
Brief Summary
Povidone iodine (PI) solution is an antimicrobial solution that can be used at hip and knee arthroplasty cases. It contains iodine that may be absorbed by the body. This study aims to investigate any absorption caused by PI solution.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Screening
Official Title:
Evaluation of the Systemic Effect of Intraoperative Diluted Povidone Iodine Irrigation Using Urine Iodine and Thyroid Function Tests in Patients Undergoing Knee-Hip Arthroplasty
Actual Study Start Date
:
Oct 1, 2022
Anticipated Primary Completion Date
:
Jan 1, 2023
Anticipated Study Completion Date
:
Feb 1, 2023
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Povidone Iodine Solution The group whom PI solution will be used at surgery |
Procedure: PI solution
3,000 cc of <2% concentrated povidone iodine solution will be used as irrigation solution at primary hip/knee arthroplasty. The PI solution was left in the joint for 3 minutes.
|
Placebo Comparator: Saline Solution The group whom only saline solution will be used at surgery |
Procedure: Saline Solution
3,000 cc of 0.9% saline solution will be used as irrigation solution at primary hip/knee arthroplasty. The saline solution was left in the joint for 3
|
Outcome Measures
Primary Outcome Measures
- Urine iodine level [postoperative first day]
Urine iodine concentration
Secondary Outcome Measures
- Thyroid hormone [postoperative 14 days]
Blood thyroid hormone levels including: TSH, T3 and T4
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- All patients with hip/knee osteoarthritis who undergo primary arthroplasty
Exclusion Criteria:
- Patients with abnormal thyroid function tests in the preoperative period, a history of the previous thyroid-related disease.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Ankara University Faculty of Medicine | Ankara | Turkey | 06100 |
Sponsors and Collaborators
- Ankara University
Investigators
- Principal Investigator: Hakan Kocaoglu, MD, Ankara University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Hakan KOCAOGLU,
M.D. Assoc. Prof.,
Ankara University
ClinicalTrials.gov Identifier:
NCT05599841
Other Study ID Numbers:
- Orthop2180
First Posted:
Oct 31, 2022
Last Update Posted:
Oct 31, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms: